COMMUNIQUÉS West-GlobeNewswire

Zealand announces successful End-of-Phase 2 meeting with FDA on glepaglutide for short bowel syndrome

26/04/2018 - 06:51

Company announcement - No. 12/2018 Zealand announces successful End-of-Phase 2 meeting with FDA on glepaglutide for short bowel syndrome Glepaglutide is in development as a new treatment option for patients with short [...]

Medibio Announces Scientific Advisory Board

26/04/2018 - 06:00

Led by Board of Director Franklyn Prendergast, M.D., Ph.D. and Chief Medical Officer Archie Defillo, M.D. Key external members include Martin Chapman, M.D.; Joel Ehrenkranz, M.D.; Mark A. Frye, M.D.; Lawrence Hunter, Ph [...]

Western Canadian Cannabis Use: Proprietary Study Indicates Half of Western Canadians Are Cannabis Users, Lapsed Users, or Interested in Trying Cannabis

26/04/2018 - 02:09

EDMONTON, Alberta, April 25, 2018 (GLOBE NEWSWIRE) -- Modern Leaf, an industry leading cannabis education and e-commerce platform, recently commissioned a research study of 2,005 Western Canadians from Manitoba, [...]

Eloxx Pharmaceuticals Announces Uplisting to Nasdaq and Pricing of $50 Million Public Offering of Common Stock

26/04/2018 - 00:22

WALTHAM, Mass., April 25, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (“Eloxx”) (Nasdaq: ELOX ) today announced the pricing of an underwritten public offering of 5,130,000 shares of its common stock at a price [...]

Nextech to Showcase Enhanced Cloud-Based Technology at The Aesthetic Meeting 2018

25/04/2018 - 23:39

Full suite of Electronic Medical Record and Practice Management solutions now include new reporting and mobility functionalities for plastic surgeons TAMPA, Fla., April 25, 2018 (GLOBE NEWSWIRE) -- Nextech Systems , a [...]

Dentsply Sirona Declares Quarterly Cash Dividend

25/04/2018 - 23:15

YORK, Pa., April 25, 2018 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY ), The Dental Solutions Company TM , announced that its Board of Directors declared a quarterly cash dividend of $0. [...]

Paratek Pharmaceuticals to Report First Quarter 2018 Financial Results on May 9, 2018

25/04/2018 - 23:03

BOSTON, April 25, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK ), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]

Progenics Pharmaceuticals Announces Presentations at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

25/04/2018 - 23:00

Pivotal Phase 2 AZEDRA Data Selected for Oral Presentation NEW YORK, April 25, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX ), an oncology company developing innovative medicines and imaging [...]

R1 RCM to Release First Quarter 2018 Results on May 9

25/04/2018 - 23:00

CHICAGO, April 25, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM ), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced it expects to release [...]

Dentsply Sirona to Host First Quarter 2018 Conference Call on May 7th

25/04/2018 - 23:00

YORK, Pa., April 25, 2018 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY ), The Dental Solutions Company™, today announced that the Company will host an investor conference call and live [...]

Osiris Announces New Peer-Reviewed Publication Summarizing Clinical Outcomes of Viable Cryopreserved Placental Membranes for Management of Chronic Diabetic Foot Ulcers in Real World Setting

25/04/2018 - 22:30

COLUMBIA, Md., April 25, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (OTC Pink:OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine [...]

BeyondSpring to Present Neutropenia Clinical Trial Data on Lead Asset, Plinabulin, at 2018 ASCO Annual Meeting

25/04/2018 - 22:30

NEW YORK, April 25, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ), a global clinical-stage biopharmaceutical company focused on the development of transformative cancer therapies, today announced that the [...]

FDA Determines that Afrezza REMS Communication Plan Has Met Goals and REMS No Longer Necessary

25/04/2018 - 22:30

WESTLAKE VILLAGE, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD ), focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as [...]

Dyadic International to Announce First Quarter 2018 Financial Results and Host Conference Call on Thursday May 10, 2018

25/04/2018 - 22:30

JUPITER, Fla., April 25, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 expression system to help [...]

Vital Therapies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

25/04/2018 - 22:30

SAN DIEGO, April 25, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL ), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today reported [...]

Burcon Announces Delisting From Nasdaq Capital Market

25/04/2018 - 22:22

VANCOUVER, British Columbia, April 25, 2018 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU ) (NASDAQ: BUR ) (“Burcon” or the “Company”), a leader in natural product extraction, purification and isolation [...]

Golden Leaf Holdings Appoints Rick Miller to Board of Directors

25/04/2018 - 22:05

TORONTO, April 25, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company built around recognized brands, today announced [...]

Conatus Pharmaceuticals to Report First Quarter 2018 Financial Results

25/04/2018 - 22:05

SAN DIEGO, April 25, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq: CNAT ) today announced that it will report financial results for the first quarter ended March 31, 2018, after the market close on [...]

Marrone Bio Innovations and Lidorr Chemicals Ltd. Sign Distribution Agreement in Israel

25/04/2018 - 22:05

DAVIS, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ: MBII ) (MBI) and Lidorr Chemicals Ltd. (LCL) today announced their partnership to distribute a range of novel biopesticides for [...]